Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential to help in treating many different types of cancers. Here are some highlights from data and learnings presented in Chicago.
ASCO17: Day 3 Immunotherapy Highlights
Read Previous Article
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Supporters, scientists, patients, and advocates participated in CRI’s annual Wear White Day for a Future Immune to Cancer on June 14, 2019.
CRI hosted a Twitter Chat, moderated by STAT’s Sharon Begley, discussing takeaways from the ASCO19 conference last week.